Revathy Carnagarin - Concepedia

Author

Revathy Carnagarin

Royal Perth Hospital ORCID

Also Known As

Ani T Gevorkyan, C Revathy, C. Revathy, R Carnagarin, R. Carnagarin, Revathy C, Revathy Carnagarin

131

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Royal Perth Hospital The University of Western Australia Baker Heart and Diabetes Institute Curtin University Hospital Research Foundation

About

Revathy Carnagarin is an author at Royal Perth Hospital specializing in medicine, molecular physiology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	434
2	Cell Biology	3	3	56
3	Cellular Physiology	2	2	41
4	Health Sciences	1	1	23
5	Biochemistry	1	1	18

Revathy Carnagarin

Publications

853

Citations

H-Index

Page 1

	Year	Citations
SGLT2 Inhibitor–Induced Sympathoinhibition Lakshini Y. Herat, Aaron L. Magno, Caroline Rudnicka, JACC Basic to Translational Science HypertensionGlucose HomeostasisSglt2 Inhibitor–induced SympathoinhibitionPharmacotherapyCardiovascular Function	2020	227
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial Clara K Chow, Emily Atkins, Graham S. Hillis, The Lancet HypertensionAntihypertensive TherapyBlood Pressure MedicinesBlood Pressure ControlPharmacotherapy	2021	139
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications David E. Kandzari, Raymond R. Townsend, Kazuomi Kario, Journal of the American College of Cardiology	2023	93
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension Gianni Sesa‐Ashton, Janis M. Nolde, Ida Muente, Hypertension	2023	77
<i>In-vitro</i>evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor Chun Yuen Jerry Wong, Jorge Martinez, Revathy Carnagarin, Journal of Pharmacy and Pharmacology	2017	38
Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension Shaun Frost, Janis M. Nolde, Justine Chan, Scientific Reports	2021	33
Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes Natalie C. Ward, Revathy Carnagarin, Janis M. Nolde, Journal of Hypertension	2022	24
PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes Revathy Carnagarin, Arun Dharmarajan, Crispin R. Dass Molecular and Cellular Endocrinology Glucose HomeostasisInsulin SignalingCellular PhysiologyInsulin-dependent Molecular PathwaysMetabolic Syndrome	2015	23
Nocturnal hypertension: a common phenotype in a tertiary clinical setting associated with increased arterial stiffness and central blood pressure Janis M. Nolde, Márcio Galindo Kiuchi, Leslie Marisol Lugo‐Gavidia, Journal of Hypertension	2020	19
Female Gender Is Associated with Higher Susceptibility of Weight Induced Arterial Stiffening and Rise in Blood Pressure Junli Zuo, Huijuan Chao, Biwen Tang, Journal of Clinical Medicine	2021	19

Page 1